AFX-2101

N/A

Report date: 2023/01/07 22:56:50
NME

Base Information

Drug NameAFX-2101
Drug Alias NameAFX-2101AFX 2101
ClassificationSmall molecules
Mechanisms of ActionHigh Mobility Group Proteins modulators
TargetsHigh Mobility Group Proteins
Therapy Area/IndicationsCentral nervous system trauma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAfecta Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAfecta Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsCentral nervous system trauma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A